➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
Johnson and Johnson
Medtronic
McKesson
Boehringer Ingelheim

Last Updated: October 28, 2021

DrugPatentWatch Database Preview

METAXALONE Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

Which patents cover Metaxalone, and what generic alternatives are available?

Metaxalone is a drug marketed by Actavis Labs Fl Inc, Amneal Pharms, Ingenus Pharms Llc, Lannett Co Inc, Mountain, Primus Pharms, Rising, Sandoz, and Sciegen Pharms Inc. and is included in nine NDAs.

The generic ingredient in METAXALONE is metaxalone. There are twenty drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the metaxalone profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Metaxalone

A generic version of METAXALONE was approved as metaxalone by SANDOZ on March 31st, 2010.

  Free Forever Trial

Drug patent expirations by year for METAXALONE
Drug Prices for METAXALONE

See drug prices for METAXALONE

Drug Sales Revenue Trends for METAXALONE

See drug sales revenues for METAXALONE

Recent Clinical Trials for METAXALONE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Rothman Institute OrthopaedicsN/A
Montefiore Medical CenterPhase 4

See all METAXALONE clinical trials

Pharmacology for METAXALONE
Paragraph IV (Patent) Challenges for METAXALONE
Tradename Dosage Ingredient NDA Submissiondate
SKELAXIN TABLET;ORAL metaxalone 013217 2004-11-04

US Patents and Regulatory Information for METAXALONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Fl Inc METAXALONE metaxalone TABLET;ORAL 203695-001 Jun 15, 2017 AB RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Rising METAXALONE metaxalone TABLET;ORAL 208774-001 Sep 24, 2018 AB RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Lannett Co Inc METAXALONE metaxalone TABLET;ORAL 204770-001 Nov 22, 2016 AB RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Sandoz METAXALONE metaxalone TABLET;ORAL 040445-001 Mar 31, 2010 AB RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Amneal Pharms METAXALONE metaxalone TABLET;ORAL 203399-001 Jun 21, 2013 AB RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Ingenus Pharms Llc METAXALONE metaxalone TABLET;ORAL 213836-001 Oct 21, 2020 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
Johnson and Johnson
Medtronic
McKesson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.